Irbesartan and Hydrochlorothiazide
- Product NDC
- 71335-2099
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203072
- Marketing category
- ANDA
- Substance
- HYDROCHLOROTHIAZIDE; IRBESARTAN
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71335-2099-1 | 30 TABLET in 1 BOTTLE (71335-2099-1) | 20220606 | | No | Historical |
| 71335-2099-2 | 90 TABLET in 1 BOTTLE (71335-2099-2) | 20220606 | | No | Historical |
| 71335-2099-3 | 28 TABLET in 1 BOTTLE (71335-2099-3) | 20220606 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| 85494404-484c-45a1-8487-f9eb2a76490d | These highlights do not include all the information needed to use IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for IRBESARTAN and HYDROCHLOROTHIAZIDE TABLETS.IRBESARTAN and HYDROCHLOROTHIAZIDE tablets, for oral use Initial U.S. Approval: 1997 | Bryant Ranch Prepack | 2023-11-14 | HUMAN PRESCRIPTION DRUG LABEL | 102 |